- published: 01 Feb 2011
- views: 1271
The National Institute of Allergy and Infectious Diseases (NIAID) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.
NIAID has "intramural" (in-house) laboratories in Maryland and Montana, and funds research conducted by scientists at institutions in the United States and throughout the world. NIAID also works closely with partners in academia, industry, government, and non-governmental organizations in multifaceted and multidisciplinary efforts to address emerging health challenges such as the pandemic H1N1/09 virus.
NIAID traces its origins to a small laboratory established in 1887 at the Marine Hospital on Staten Island, New York (now the Bayley Seton Hospital). Officials of the Marine Hospital Service in New York decided to open a research laboratory to study the link between microscopic organisms and infectious diseases. Dr. Joseph J. Kinyoun, a medical officer with the Marine Hospital Service, was selected to create this laboratory, which he called a "laboratory of hygiene."
Anthony Stephen "Tony" Fauci (born December 24, 1940) is an American immunologist who has made substantial contributions to HIV/AIDS research and other immunodeficiencies, both as a scientist and as the head of the National Institute of Allergy and Infectious Diseases (NIAID).
Anthony Stephen Fauci was born on December 24, 1940, in Brooklyn, New York, to Stephen A. Fauci, a pharmacist, and Eugenia A. Fauci, a homemaker. He is of Italian descent and grew up Catholic. He graduated from Regis High School in New York City. He went on to attend the College of the Holy Cross and received his M.D. from Cornell University Medical College in 1966. He then completed an internship and residency at The New York Hospital-Cornell Medical Center.
In 1968 he came to the National Institutes of Health (NIH) as a clinical associate in the Laboratory of Clinical Investigation (LCI) in NIAID. In 1974 he became Head of the Clinical Physiology Section, LCI, and in 1980 was appointed Chief of the Laboratory of Immunoregulation, a position he still holds. In 1984 he became Director of NIAID, which has the responsibility for an extensive research portfolio of basic and applied research on infectious and immune-mediated illnesses.
A food allergy is an abnormal immune response to food. The signs and symptoms may range from mild to severe. They may include itchiness, swelling of the tongue, vomiting, diarrhea, hives, trouble breathing, or low blood pressure. This typically occurs within minutes to several hours of exposure. When the symptoms are severe it is known as anaphylaxis. Food intolerance and food poisoning are separate conditions.
Common foods involved include cow's milk, peanuts, eggs, shellfish, tree nuts, wheat, rice, and fruit. Which allergies are most common depends on the country. Risk factors include a family history of allergies, vitamin D deficiency, obesity, and high levels of cleanliness. Allergies occur when immunoglobulin E (IgE), part of the body's immune system, binds to food molecules. It is usually a protein in the food that is the problem. This triggers the release of inflammatory chemicals such as histamine. Diagnosis is usually based on a medical history, elimination diet, skin prick test, blood tests for food-specific IgE antibodies, or oral food challenge.
Rocky Mountain Laboratories (RML) is part of the NIH Intramural Research Program and is located in Hamilton, Montana. Operated by the National Institute of Allergy and Infectious Diseases, RML conducts research on maximum containment pathogens such as Ebola as well as research on prions and intracellular pathogens such as Coxiella burnetti and Francisella tularensis. RML operates one of the few Biosafety level 4 laboratories in the United States, as well as Biosafety level 3 and ABSL3/4 laboratories.
The National may refer to:
News media:
Other:
Each year, millions of people are infected with mosquito-borne diseases. By funding and conducting research into mosquitoes and the diseases they carry, NIAID is dedicated to finding preventions, treatments and cures for malaria, Zika, dengue, chikungunya, and a host of other illnesses. Featured NIAID-funded projects and grantees, in order of first appearance: - MosquitoSphere, experimental huts, and insecticidal fungus research from Raymond St. Leger, Ph.D., University of Maryland, College Park: http://entomology.umd.edu/st-leger-raymond-j.html - Novel insecticide research from Catherine Hill, Ph.D., Purdue University: https://www2.ag.purdue.edu/Pages/Profile.aspx?strAlias=hillca - Experimental huts for insecticide resistance research from Matthew Thomas, Ph.D., Penn State College of...
DOCK8 deficiency is a rare immune disorder that was identified at NIAID. Learn about the disease and how research at NIAID helps patients with immune disorders.
An overview and tour of the Integrated Research Facility, a state-of-the-art laboratory building on the campus of NIAID's Rocky Mountain Laboratories in Hamilton, Montana.
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) describe a promising nasal brush test that can rapidly and accurately diagnose Creutzfeldt-Jakob disease (CJD), an incurable and ultimately fatal neurodegenerative disorder.
The National Institute of Allergy and Infectious Diseases explains food allergy and offers tips on how to manage the condition.
The National Institute of Allergy and Infectious Diseases explains the emergence and potential spread of new influenza viruses.
An overview of the NIAID Integrated Research Facility, a state-of-the-art laboratory complex in Frederick, Maryland.
Have you ever wondered why you need a flu vaccination each year? The National Institute of Allergy and Infectious Diseases explains the ever-changing nature of influenza viruses.
Mosquitoes can carry diseases, including Zika, chikungunya, malaria, and dengue. NIAID researchers have begun a Phase 1 trial to test a vaccine that could provide broad protection against all of these illnesses, as well as other mosquito-borne diseases.
NIAID's Joshua Milner, M.D., and Jonathan Lyons, M.D., describe research that identified a genetic explanation for a syndrome characterized by multiple frustrating and difficult-to-treat symptoms. For more information about inherited elevated tryptase levels, see https://www.niaid.nih.gov/research/hereditary-alpha-tryptasemia-faq
A look at tularemia, a serious infectious disease being studied by NIAID researchers.
Through partnerships with community healthcare providers, NIAID conducts clinical research to find better ways to prevent, diagnose, and treat disease.
Dr. Sonja Best, a virologist at NIAID's Rocky Mountain Laboratories, won a 2010 Presidential Early Career Award for Scientists and Engineers (PECASE), the highest honor bestowed by the U.S. Government on scientists and engineers beginning their independent careers.
Hugh Sampson, MD of the Mt. Sinai School of Medicine and The Jaffe Food Allergy Institute presents on the NIAID Food Allergy Guidelines and allergen component diagnostics. The program was recorded on Feb 24th at a Thermo Fisher Scientific sponsored event during the AAAAI 2013 annual meeting.
Ending the HIV/AIDS Pandemic: Follow the Science - Anthony S. Fauci, MD The following talk via video by Dr. Anthony S. Fauci of NIAID, National Institutes of Health was the opening keynote address on March 21, 2016 of the joint Keystone Symposia conferences on “HIV Vaccines” and “HIV Persistence: Pathogenesis and Eradication” at the Resort at Squaw Creek, Olympic Valley, CA. Dr. Fauci had to cancel his plans to attend in person due to schedule demands as a result of the emerging Zika crisis. About Anthony S. Fauci (from NIH Site): Dr. Fauci was appointed Director of NIAID in 1984. He oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculo...
This video highlights the refinement of the NIAID HIV/AIDS Clinical Trials Units (CTUs). Speakers: Manizhe Payton, Bola Adedeji Date: 8/4/17
This video is about Early Introduction of Peanut: New 2017 NIAID Guidelines
J'aurais voulu changer les choses
Changer le monde
Avoir ce qu'il y a de mieux
J'aurais voulu changer les choses
Changer le monde
Pour être encore un peu hereuse
J'aurais voulu te parler et ne plus faire comme avant
Attendre et espérer, on a perdu trop de temps
Je n'avais plus les pieds sur terre, je ne croyais qu'en mes prières
Mais les rêves qu'on a faits se sont tous envolés
Je n'avais plus les pieds sur terre
Je ne savais qu'être sincère
Si seulement j'avais su
Changer les choses
Changer le monde
Avoir ce qu'il y a de mieux
J'aurais voulu changer les choses
Changer le monde
Pour être encore un peu heureuse
On a brûlé notre amour en étant trop innocents
Pour déjouer les mauvais tours à mon trop grand sentiment
On n'avait pas les pieds sur terre, on ne voulait qu'être sincères
J'y vois clair maintenant
Changer les choses
Changer le monde
Avoir ce qu'il y a de mieux
J'aurais voulu changer les choses
Changer le monde
Pour être encore un peu heureuse
Changer les choses
Changer le monde
Avoir ce qu'il y a de mieux
J'aurais voulu changer les choses
Changer le monde
Pour être encore un peu heureuse
Changer de vie
Changer aussi
J'ai juste voulu changer d'histoire
Encore y croire
Changer de vie
Changer aussi
J'ai juste voulu changer de vie
J'aurais voulu changer les choses
Changer le monde
Avoir ce qu'il y a de mieux
J'aurais voulu changer les choses
Changer le monde
Pour être encore un peu heureuse
Changer de vie
Changer aussi
J'ai juste voulu changer d'histoire
Encore y croire
Changer de vie
Changer aussi
J'ai juste voulu changer de vie
Changer de vie
Changer aussi
J'ai juste voulu changer d'histoire
Encore y croire
Changer de vie